Coya Therapeutics to Present at the BTIG Virtual biotechnology Conference 2023
Dr. Reddy's Proposed Rituximab Biosimilar Application Accepted for Review by USFDA, EMA and MHRA
Coya Therapeutics presents promising biomarker data for Alzheimer's disease treatment
Dr. Reddy's rituximab biosimilar candidate undergoes regulatory review in the US, EU and UK
Dr. Reddy's rituximab biosimilar candidate undergoes regulatory review in the US, EU and UK
Dr. Reddy's rituximab biosimilar candidate undergoes regulatory review in the US, EU and UK